Form S-8 - Securities to be offered to employees in employee benefit plans:
SEC Accession No. 0001104659-20-124493
Filing Date
2020-11-12
Accepted
2020-11-12 17:23:15
Documents
5
Effectiveness Date
2020-11-12

Document Format Files

Seq Description Document Type Size
1 FORM S-8 tm2035651-1_s8.htm S-8 89044
2 EXHIBIT 5.1 tm2035651d1_ex5-1.htm EX-5.1 10233
3 EXHIBIT 23.2 tm2035651d1_ex23-2.htm EX-23.2 2236
4 EXHIBIT 23.3 tm2035651d1_ex23-3.htm EX-23.3 2415
5 GRAPHIC tm2035651d1_ex5-1img001.jpg GRAPHIC 5193
  Complete submission text file 0001104659-20-124493.txt   112207
Mailing Address 535 BOYLSTON STREET BOSTON MA 02116
Business Address 535 BOYLSTON STREET BOSTON MA 02116 6095104718
Aprea Therapeutics, Inc. (Filer) CIK: 0001781983 (see all company filings)

EIN.: 000000000 | State of Incorp.: DE | Fiscal Year End: 1231
Type: S-8 | Act: 33 | File No.: 333-250043 | Film No.: 201308083
SIC: 2834 Pharmaceutical Preparations